The report provides value (USD million) data for all the industry categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides industry player shares and distribution shares data for each of the aforementioned industry categories. The report is supplemented with global corporate-level profiles of the key industry participants.


Scope of the Research

- Countries covered include Australia, China, India and Japan.
- Industry size and market share data for Drug Delivery Devices industry categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized industry revenues (USD million) data for each of the industry categories in each of the country. Data from 2003 to 2010, projection forward for 7 years to 2017.
- 2010 industry player shares and distribution shares data for each of the industry categories and countries.
- Global corporate-level profiles of key industry players operating within the Asia-Pacific Drug Delivery Devices industry ..
- Key Companies covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Terumo Corporation, Sunovion, NIPRO CORPORATION and others.

Reasons to buy

- Develop innovative strategies by selecting the key market segment expected to grow .
- Develop successful market-entry strategies .
- Understand and respond to your competition by identifying who-stands-where in the Asia-Pacific Drug Delivery Devices competitive landscape.
- Facilitate better investment decision making by identifying the key industry sectors expected to register strong growth in the near future.
- What are the best distribution channels and what’s the most preferred mode of product distribution – Identify, understand and decide.

Table Of Contents

1 Table of Contents

I Table of Contents 2
I. 1 List of Data tables 7
I. 2 List of Charts 9

II Introduction 11
II. 1 About this Report and the Author 11

III Drug Delivery Devices in Asia-Pacific 12
III. 1 Drug Delivery Devices Cross Country Comparison, Sales (USD Million), from 2003 to 2017 12
III. 2 Drug Delivery Devices, Asia-Pacific, Overall Sales (USD Million), from 2003 to 2017 13
III. 3 Drug Delivery Devices, Asia-Pacific, Segment Volume (Units), from 2003 to 2017 20
III. 4 Drug Delivery Devices, Asia-Pacific, Firms share (2009-2010) 25

IV Drug Delivery Devices In Japan 27
IV. 1 Drug Delivery Devices, Japan, Overall Sales (USD Million), from 2003 to 2017 27
IV. 2 Drug Delivery Devices, Japan, Segment Volume (Units), from 2003 to 2017 33
IV. 3 Drug Delivery Devices, Japan, Distribution Channel (2009-2010) 38
IV. 3.1 Central Venous Catheters, Japan, Distribution Channel (2009-2010) 38
IV. 3.2 Infusion Systems, Japan, Distribution Channel (2009-2010) 38
IV. 3.3 Metered Dose Inhaler Devices, Japan, Distribution Channel (2009-2010) 39
IV. 3.4 Needle Free Injections, Japan, Distribution Channel (2009-2010) 39
IV. 4 Drug Delivery Devices, Japan, Market Shares (2009-2010) 40
IV. 4.1 Drug Delivery Devices, Japan, Market Shares (2009-2010) 40
IV. 4.2 Central Venous Catheters, Japan, Market Shares (2009-2010) 42
IV. 4.3 Infusion Systems, Japan, Market Shares (2009-2010) 44
IV. 4.4 Metered Dose Inhaler Devices, Japan, Market Shares (2009-2010) 46
IV. 4.5 Needle Free Injections, Japan, Market Shares (2009-2010) 47

V Drug Delivery Devices In Australia 48
V. 1 Drug Delivery Devices, Australia, Overall Sales (USD Million), from 2003 to 2017 48
V. 2 Drug Delivery Devices, Australia, Segment Volume (Units), from 2003 to 2017 54
V. 3 Drug Delivery Devices, Australia, Distribution Channel (2009-2010) 59
V. 3.1 Central Venous Catheters, Australia, Distribution Channel (2009-2010) 59
V. 3.2 Infusion Systems, Australia, Distribution Channel (2009-2010) 59
V. 3.3 Metered Dose Inhaler Devices, Australia, Distribution Channel (2009-2010) 60
V. 3.4 Needle Free Injections, Australia, Distribution Channel (2009-2010) 60
V. 4 Drug Delivery Devices, Australia, Market Shares (2009-2010) 61
V. 4.1 Drug Delivery Devices, Australia, Market Shares (2009-2010) 61
V. 4.2 Central Venous Catheters, Australia, Market Shares (2009-2010) 63
V. 4.3 Infusion Systems, Australia, Market Shares (2009-2010) 65
V. 4.4 Metered Dose Inhaler Devices, Australia, Market Shares (2009-2010) 67
V. 4.5 Needle Free Injections, Australia, Market Shares (2009-2010) 68

VI Drug Delivery Devices In China 69
VI. 1 Drug Delivery Devices, China, Overall Sales (USD Million), from 2003 to 2017 69
VI. 2 Drug Delivery Devices, China, Segment Volume (Units), from 2003 to 2017 75
VI. 3 Drug Delivery Devices, China, Distribution Channel (2009-2010) 80
VI. 3.1 Central Venous Catheters, China, Distribution Channel (2009-2010) 80
VI. 3.2 Infusion Systems, China, Distribution Channel (2009-2010) 80
VI. 3.3 Metered Dose Inhaler Devices, China, Distribution Channel (2009-2010) 81
VI. 3.4 Needle Free Injections, China, Distribution Channel (2009-2010) 81
VI. 4 Drug Delivery Devices, China, Market Shares (2009-2010) 82
VI. 4.1 Drug Delivery Devices, China, Market Shares (2009-2010) 82
VI. 4.2 Central Venous Catheters, China, Market Shares (2009-2010) 84
VI. 4.3 Infusion Systems, China, Market Shares (2009-2010) 86
VI. 4.4 Metered Dose Inhaler Devices, China, Market Shares (2009-2010) 88
VI. 4.5 Needle Free Injections, China, Market Shares (2009-2010) 90

VII Drug Delivery Devices In India 91
VII. 1 Drug Delivery Devices, India, Overall Sales (USD Million), from 2003 to 2017 91
VII. 2 Drug Delivery Devices, India, Segment Volume (Units), from 2003 to 2017 97
VII. 3 Drug Delivery Devices, India, Distribution Channel (2009-2010) 102
VII. 3.1 Central Venous Catheters, India, Distribution Channel (2009-2010) 102
VII. 3.2 Infusion Systems, India, Distribution Channel (2009-2010) 102
VII. 3.3 Metered Dose Inhaler Devices, India, Distribution Channel (2009-2010) 103
VII. 3.4 Needle Free Injections, India, Distribution Channel (2009-2010) 103
VII. 4 Drug Delivery Devices, India, Market Shares (2009-2010) 104
VII. 4.1 Drug Delivery Devices, India, Market Shares (2009-2010) 104
VII. 4.2 Central Venous Catheters, India, Market Shares (2009-2010) 106
VII. 4.3 Infusion Systems, India, Market Shares (2009-2010) 108
VII. 4.4 Metered Dose Inhaler Devices, India, Market Shares (2009-2010) 110

VIII Overview of Key Firms in Asia-Pacific Drug Delivery Devices March ket 112
VIII. 1 GlaxoSmithKline plc 112
VIII. 1.1 Company Profile 112
VIII. 1.2 Share in the Asia-Pacific Drug Delivery Devices March ket 112
VIII. 2 Boehringer Ingelheim GmbH 113
VIII. 2.1 Company Profile 113
VIII. 2.2 Share in the Asia-Pacific Drug Delivery Devices March ket 113
VIII. 3 AstraZeneca International plc 114
VIII. 3.1 Company Profile 114
VIII. 3.2 Share in the Asia-Pacific Drug Delivery Devices March ket 114
VIII. 4 Terumo Corporation 115
VIII. 4.1 Company Profile 115
VIII. 4.2 Share in the Asia-Pacific Drug Delivery Devices March ket 115
VIII. 5 Sunovion 116
VIII. 5.1 Share in the Asia-Pacific Drug Delivery Devices March ket 116
VIII. 6 Baxter International Inc. 117
VIII. 6.1 Company Profile 117
VIII. 6.2 Share in the Asia-Pacific Drug Delivery Devices March ket 117
VIII. 7 NIPRO CORPORATION 118
VIII. 7.1 Company Profile 118
VIII. 8 JMS CO., LTD. 118
VIII. 8.1 Company Profile 118
VIII. 9 CareFusion Corporation 118
VIII. 9.1 Company Profile 118
VIII. 10 Smiths Medical 119
VIII. 10.1 Company Profile 119
VIII. 11 Hospira, Inc. 119
VIII. 11.1 Company Profile 119
VIII. 12 Fresenius Kabi AG 119
VIII. 12.1 Company Profile 119
VIII. 13 3M Health Care 120
VIII. 13.1 Company Profile 120
VIII. 14 Teleflex Incorporated 120
VIII. 14.1 Company Profile 120
VIII. 15 Medtronic, Inc. 120
VIII. 15.1 Company Profile 120
VIII. 16 B. Braun Melsungen AG 121
VIII. 16.1 Company Profile 121
VIII. 17 Consort Medical plc 121
VIII. 17.1 Company Profile 121
VIII. 18 Edwards Lifesciences Corporation 121
VIII. 18.1 Company Profile 121
VIII. 19 Cipla Ltd. 122
VIII. 19.1 Company Profile 122
VIII. 20 INJEX - Equidyne Systems 122
VIII. 20.1 Company Profile 122
VIII. 21 Bioject Medical Technologies Inc. 123
VIII. 21.1 Company Profile 123

IX Drug Delivery Devices March ket Pipeline Products 124

X Appendix 128
X. 1 Definitions of March kets Covered in the Report 129
X. 1.1 Drug Delivery Devices 129
X. 2 Research Methodology 130
X. 3 Secondary Research 130
X. 4 Primary Research 130
X. 5 Models 131
X. 6 Forecasted data s 131
X. 7 Expert Panels 131
X. 8 GlobalData Consulting 132
X. 9 Currency Conversion 132
X. 10 Contact Us 132
X. 11 Disclaimer 132

1.1

List of Tables


Data table 1: Drug Delivery Devices, Cross Country Comparison, Sales (USD Million), from 2003 to 2017 12
Data table 2: Drug Delivery Devices, Asia-Pacific, Overall Sales (USD Million), from 2003 to 2017 14
Data table 3: Drug Delivery Devices, Asia-Pacific, Cross-Category Analysis, from 2003 to 2017 15
Data table 4: Drug Delivery Devices, Asia-Pacific, Overall Sales (USD Million), Historical data, from 2003 to 2010 17
Data table 5: Drug Delivery Devices, Asia-Pacific, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 19
Data table 6: Drug Delivery Devices, Asia-Pacific, Segment Volume (Units), from 2003 to 2017 20
Data table 7: Drug Delivery Devices, Asia-Pacific, Segment Volume (Units), Historical data, from 2003 to 2010 22
Data table 8: Drug Delivery Devices, Asia-Pacific, Segment Volume (Units), Forecasted data, from 2010 to 2017 24
Data table 9: Drug Delivery Devices, Asia-Pacific, Firms share by Sales (USD Million), from 2009 to 2010 26
Data table 10: Drug Delivery Devices, Japan, Overall Sales (USD Million), from 2003 to 2017 28
Data table 11: Drug Delivery Devices, Japan, Overall Sales (USD Million), Historical data, from 2003 to 2010 30
Data table 12: Drug Delivery Devices, Japan, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 32
Data table 13: Drug Delivery Devices, Japan, Segment Volume (Units), from 2003 to 2017 33
Data table 14: Drug Delivery Devices, Japan, Segment Volume (Units), Historical data, from 2003 to 2010 35
Data table 15: Drug Delivery Devices, Japan, Segment Volume (Units), Forecasted data, from 2010 to 2017 37
Data table 16: Central Venous Catheters, Japan, Distribution Channel by Sales (USD Million), from 2009 to 2010 38
Data table 17: Infusion Systems, Japan, Distribution Channel by Sales (USD Million), from 2009 to 2010 38
Data table 18: Metered Dose Inhaler Devices, Japan, Distribution Channel by Sales (USD Million), from 2009 to 2010 39
Data table 19: Needle Free Injections, Japan, Distribution Channel by Sales (USD Million), from 2009 to 2010 39
Data table 20: Drug Delivery Devices, Japan, Market Shares by Sales (USD Million), from 2009 to 2010 41
Data table 21: Central Venous Catheters, Japan, Market Shares by Sales (USD Million), from 2009 to 2010 43
Data table 22: Infusion Systems, Japan, Market Shares by Sales (USD Million), from 2009 to 2010 45
Data table 23: Metered Dose Inhaler Devices, Japan, Market Shares by Sales (USD Million), from 2009 to 2010 46
Data table 24: Needle Free Injections, Japan, Market Shares by Sales (USD Million), from 2009 to 2010 47
Data table 25: Drug Delivery Devices, Australia, Overall Sales (USD Million), from 2003 to 2017 49
Data table 26: Drug Delivery Devices, Australia, Overall Sales (USD Million), Historical data, from 2003 to 2010 51
Data table 27: Drug Delivery Devices, Australia, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 53
Data table 28: Drug Delivery Devices, Australia, Segment Volume (Units), from 2003 to 2017 54
Data table 29: Drug Delivery Devices, Australia, Segment Volume (Units), Historical data, from 2003 to 2010 56
Data table 30: Drug Delivery Devices, Australia, Segment Volume (Units), Forecasted data, from 2010 to 2017 58
Data table 31: Central Venous Catheters, Australia, Distribution Channel by Sales (USD Million), from 2009 to 2010 59
Data table 32: Infusion Systems, Australia, Distribution Channel by Sales (USD Million), from 2009 to 2010 59
Data table 33: Metered Dose Inhaler Devices, Australia, Distribution Channel by Sales (USD Million), from 2009 to 2010 60
Data table 34: Needle Free Injections, Australia, Distribution Channel by Sales (USD Million), from 2009 to 2010 60
Data table 35: Drug Delivery Devices, Australia, Market Shares by Sales (USD Million), from 2009 to 2010 62
Data table 36: Central Venous Catheters, Australia, Market Shares by Sales (USD Million), from 2009 to 2010 64
Data table 37: Infusion Systems, Australia, Market Shares by Sales (USD Million), from 2009 to 2010 66
Data table 38: Metered Dose Inhaler Devices, Australia, Market Shares by Sales (USD Million), from 2009 to 2010 67
Data table 39: Needle Free Injections, Australia, Market Shares by Sales (USD Million), from 2009 to 2010 68
Data table 40: Drug Delivery Devices, China, Overall Sales (USD Million), from 2003 to 2017 70
Data table 41: Drug Delivery Devices, China, Overall Sales (USD Million), Historical data, from 2003 to 2010 72
Data table 42: Drug Delivery Devices, China, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 74
Data table 43: Drug Delivery Devices, China, Segment Volume (Units), from 2003 to 2017 75
Data table 44: Drug Delivery Devices, China, Segment Volume (Units), Historical data, from 2003 to 2010 77
Data table 45: Drug Delivery Devices, China, Segment Volume (Units), Forecasted data, from 2010 to 2017 79
Data table 46: Central Venous Catheters, China, Distribution Channel by Sales (USD Million), from 2009 to 2010 80
Data table 47: Infusion Systems, China, Distribution Channel by Sales (USD Million), from 2009 to 2010 80
Data table 48: Metered Dose Inhaler Devices, China, Distribution Channel by Sales (USD Million), from 2009 to 2010 81
Data table 49: Needle Free Injections, China, Distribution Channel by Sales (USD Million), from 2009 to 2010 81
Data table 50: Drug Delivery Devices, China, Market Shares by Sales (USD Million), from 2009 to 2010 83
Data table 51: Central Venous Catheters, China, Market Shares by Sales (USD Million), from 2009 to 2010 85
Data table 52: Infusion Systems, China, Market Shares by Sales (USD Million), from 2009 to 2010 87
Data table 53: Metered Dose Inhaler Devices, China, Market Shares by Sales (USD Million), from 2009 to 2010 89
Data table 54: Needle Free Injections, China, Market Shares by Sales (USD Million), from 2009 to 2010 90
Data table 55: Drug Delivery Devices, India, Overall Sales (USD Million), from 2003 to 2017 92
Data table 56: Drug Delivery Devices, India, Overall Sales (USD Million), Historical data, from 2003 to 2010 94
Data table 57: Drug Delivery Devices, India, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 96
Data table 58: Drug Delivery Devices, India, Segment Volume (Units), from 2003 to 2017 97
Data table 59: Drug Delivery Devices, India, Segment Volume (Units), Historical data, from 2003 to 2010 99
Data table 60: Drug Delivery Devices, India, Segment Volume (Units), Forecasted data, from 2010 to 2017 101
Data table 61: Central Venous Catheters, India, Distribution Channel by Sales (USD Million), from 2009 to 2010 102
Data table 62: Infusion Systems, India, Distribution Channel by Sales (USD Million), from 2009 to 2010 102
Data table 63: Metered Dose Inhaler Devices, India, Distribution Channel by Sales (USD Million), from 2009 to 2010 103
Data table 64: Needle Free Injections, India, Distribution Channel by Sales (USD Million), from 2009 to 2010 103
Data table 65: Drug Delivery Devices, India, Market Shares by Sales (USD Million), from 2009 to 2010 105
Data table 66: Central Venous Catheters, India, Market Shares by Sales (USD Million), from 2009 to 2010 107
Data table 67: Infusion Systems, India, Market Shares by Sales (USD Million), from 2009 to 2010 109
Data table 68: Metered Dose Inhaler Devices, India, Market Shares by Sales (USD Million), from 2009 to 2010 111
Data table 69: Drug Delivery Devices March ket Pipeline Products 124
Data table 70: US Dollar to Local Currency, Asia-Pacific, Average Exchange Rate from 2003 to 2010 132

1.2

List of Figures


Chart 1: Drug Delivery Devices, Cross Country Comparison, Sales (USD Million), from 2003 to 2017 12
Chart 2: Drug Delivery Devices, Asia-Pacific, Overall Sales (USD Million), from 2003 to 2017 13
Chart 3: Drug Delivery Devices, Asia-Pacific, Cross-Category Analysis, from 2003 to 2017 15
Chart 4: Drug Delivery Devices, Asia-Pacific, Overall Sales (USD Million), Historical data, from 2003 to 2010 16
Chart 5: Drug Delivery Devices, Asia-Pacific, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 18
Chart 6: Drug Delivery Devices, Asia-Pacific, Segment Volume (Units), from 2003 to 2017 20
Chart 7: Drug Delivery Devices, Asia-Pacific, Segment Volume (Units), Historical data, from 2003 to 2010 21
Chart 8: Drug Delivery Devices, Asia-Pacific, Segment Volume (Units), Forecasted data, from 2010 to 2017 23
Chart 9: Drug Delivery Devices, Asia-Pacific, Firms share (%), 2010 25
Chart 10: Drug Delivery Devices, Japan, Overall Sales (USD Million), from 2003 to 2017 27
Chart 11: Drug Delivery Devices, Japan, Overall Sales (USD Million), Historical data, from 2003 to 2010 29
Chart 12: Drug Delivery Devices, Japan, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 31
Chart 13: Drug Delivery Devices, Japan, Segment Volume (Units), from 2003 to 2017 33
Chart 14: Drug Delivery Devices, Japan, Segment Volume (Units), Historical data, from 2003 to 2010 34
Chart 15: Drug Delivery Devices, Japan, Segment Volume (Units), Forecasted data, from 2010 to 2017 36
Chart 16: Drug Delivery Devices, Japan, Market Shares (%), 2010 40
Chart 17: Central Venous Catheters, Japan, Market Shares (%), 2010 42
Chart 18: Infusion Systems, Japan, Market Shares (%), 2010 44
Chart 19: Metered Dose Inhaler Devices, Japan, Market Shares (%), 2010 46
Chart 20: Needle Free Injections, Japan, Market Shares (%), 2010 47
Chart 21: Drug Delivery Devices, Australia, Overall Sales (USD Million), from 2003 to 2017 48
Chart 22: Drug Delivery Devices, Australia, Overall Sales (USD Million), Historical data, from 2003 to 2010 50
Chart 23: Drug Delivery Devices, Australia, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 52
Chart 24: Drug Delivery Devices, Australia, Segment Volume (Units), from 2003 to 2017 54
Chart 25: Drug Delivery Devices, Australia, Segment Volume (Units), Historical data, from 2003 to 2010 55
Chart 26: Drug Delivery Devices, Australia, Segment Volume (Units), Forecasted data, from 2010 to 2017 57
Chart 27: Drug Delivery Devices, Australia, Market Shares (%), 2010 61
Chart 28: Central Venous Catheters, Australia, Market Shares (%), 2010 63
Chart 29: Infusion Systems, Australia, Market Shares (%), 2010 65
Chart 30: Metered Dose Inhaler Devices, Australia, Market Shares (%), 2010 67
Chart 31: Needle Free Injections, Australia, Market Shares (%), 2010 68
Chart 32: Drug Delivery Devices, China, Overall Sales (USD Million), from 2003 to 2017 69
Chart 33: Drug Delivery Devices, China, Overall Sales (USD Million), Historical data, from 2003 to 2010 71
Chart 34: Drug Delivery Devices, China, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 73
Chart 35: Drug Delivery Devices, China, Segment Volume (Units), from 2003 to 2017 75
Chart 36: Drug Delivery Devices, China, Segment Volume (Units), Historical data, from 2003 to 2010 76
Chart 37: Drug Delivery Devices, China, Segment Volume (Units), Forecasted data, from 2010 to 2017 78
Chart 38: Drug Delivery Devices, China, Market Shares (%), 2010 82
Chart 39: Central Venous Catheters, China, Market Shares (%), 2010 84
Chart 40: Infusion Systems, China, Market Shares (%), 2010 86
Chart 41: Metered Dose Inhaler Devices, China, Market Shares (%), 2010 88
Chart 42: Needle Free Injections, China, Market Shares (%), 2010 90
Chart 43: Drug Delivery Devices, India, Overall Sales (USD Million), from 2003 to 2017 91
Chart 44: Drug Delivery Devices, India, Overall Sales (USD Million), Historical data, from 2003 to 2010 93
Chart 45: Drug Delivery Devices, India, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 95
Chart 46: Drug Delivery Devices, India, Segment Volume (Units), from 2003 to 2017 97
Chart 47: Drug Delivery Devices, India, Segment Volume (Units), Historical data, from 2003 to 2010 98
Chart 48: Drug Delivery Devices, India, Segment Volume (Units), Forecasted data, from 2010 to 2017 100
Chart 49: Drug Delivery Devices, India, Market Shares (%), 2010 104
Chart 50: Central Venous Catheters, India, Market Shares (%), 2010 106
Chart 51: Infusion Systems, India, Market Shares (%), 2010 108
Chart 52: Metered Dose Inhaler Devices, India, Market Shares (%), 2010 110
Chart 53: GlaxoSmithKline plc, Market Shares (%), Asia-Pacific Drug Delivery Devices March ket, 2010 112
Chart 54: Boehringer Ingelheim GmbH, Market Shares (%), Asia-Pacific Drug Delivery Devices March ket, 2010 113
Chart 55: AstraZeneca PLC, Market Shares (%), Asia-Pacific Drug Delivery Devices March ket, 2010 114
Chart 56: Terumo Corporation, Market Shares (%), Asia-Pacific Drug Delivery Devices March ket, 2010 115
Chart 57: Sunovion, Market Shares (%), Asia-Pacific Drug Delivery Devices March ket, 2010 116
Chart 58: Baxter International Inc, Market Shares (%), Asia-Pacific Drug Delivery Devices March ket, 2010 117

Companies Mentioned
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
AstraZeneca International plc
Terumo Corporation
Sunovion
Baxter International Inc.
NIPRO CORPORATION
JMS CO., LTD.
CareFusion Corporation
Smiths Medical
Hospira, Inc.
Fresenius Kabi AG
3M Health Care
Teleflex Incorporated
Medtronic, Inc.
B. Braun Melsungen AG
Consort Medical plc
Edwards Lifesciences Corporation
Cipla Ltd.
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Pulmonary Drug Delivery Systems: Technologies and Global Markets

Pulmonary Drug Delivery Systems: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Receive a detailed analysis of the present and future global market for pulmonary drug delivery technologies. - Receive information on pulmonary drug delivery technologies currently ...

RNAi Drug Delivery : Technologies and Gobal Markets

RNAi Drug Delivery : Technologies and Gobal Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research report provides an in-depth assessment of recent progress and future opportunities for RNA interference (RNAi) players in major therapeutic and drug delivery areas, including infectious ...

Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • May 2014
  • by Transparency Market Research

nebulizer is a medical device used for the treatment of respiratory disorders (asthma, COPD and cystic fibrosis) that converts liquid medication into mist or aerosol. Thus, the medicine can easily reach ...

Cytotoxic Drug Delivery

May 2014 $ 2 850

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.